Field-force conversations still run on a lag. Tracking studies take weeks to return, often landing well after the launch window has closed.

KAI closes that gap. Our patentented AI analyzes acoustic, linguistic, and visual signals in consent based HCP conversations, producing NetKonnector®, a conversation-level score of connection quality available in near real time.

Commercial and medical teams use it to track HCP sentiment and objections as they surface, coaching reps on empathy and active listening to see which messages are resonating.

That signal feeds directly into a reporting layer designed for daily use, not the quarterly review cycle. Insight dashboards give commercial and medical teams a live view of sentiment and objection trends across brands and regions, and opportunity alerts flag which conversations warrant attention before the next call. Coaching nudges convert those findings into specific next steps for managers, while executive briefs deliver the same picture to leadership without waiting on a tracking study.

KAI operates globally in 35+ markets and in 99+ languages. 5 of the world's Top 10 pharmaceutical companies rely on it for commercial strategy and field coaching. McKinsey research links stronger field-force communication to a 2 to 15% revenue uplift, and NetKonnector® gives teams the evidence they need to close that gap.This is Behavioural Intelligence for Life Sciences: an objective layer between the conversations pharma teams have and the results they are driving.

KAI: Behaviour Change, Accelerated.

The Behavioural Intelligence Platform for Life Sciences